Private Capital Group’s Zimmer Biomet ZBH Stock Holding History

Private Capital Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$0	Sell	1 -539	-100%	-$63.9K	﹤0.01%	2150
2022 Q1	$69K	Sell	540 -16	-3%	-$1.93K	0.02%	530
2021 Q4	$69K	Hold	556	–	–	0.01%	557
2021 Q3	$79K	Buy	556 +67	+14%	+$9.86K	0.02%	506
2021 Q2	$77K	Sell	489 -13	-3%	-$2.11K	0.02%	508
2021 Q1	$78K	Buy	502 +1	+0.2%	+$155	0.02%	471
2020 Q4	$75K	Buy	501 +212	+73%	+$29.9K	0.01%	612
2020 Q3	$38K	Sell	289 -4	-1%	-$523	0.01%	844
2020 Q2	$34K	Hold	293	–	–	0.01%	893
2020 Q1	$29K	Hold	293	–	–	0.01%	860
2019 Q4	$42K	Hold	293	–	–	0.01%	819
2019 Q3	$39K	Sell	293 -336	-53%	-$43.4K	0.01%	890
2019 Q2	$68K	Buy	629 +182	+41%	+$21.3K	0.02%	529
2019 Q1	$56K	Sell	447 -43	-9%	-$4.89K	0.01%	712
2018 Q4	$49K	Hold	490	–	–	0.01%	674
2018 Q3	$62K	Sell	490 -183	-27%	-$21.8K	0.01%	617
2018 Q2	$72K	Hold	673	–	–	0.02%	542
2018 Q1	$71K	Sell	673 -344	-34%	-$39.9K	0.02%	528
2017 Q4	$84	Buy	+1,017	New	+$115K	0.02%	481

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Private Capital Group's ZBH Position: Q2 2022 in Review

Private Capital Group reduced its Zimmer Biomet (ZBH) stake by 100% in Q2 2022, selling an estimated $63.9K and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

Private Capital Group first reported a position in ZBH in Q4 2017 and has held it in 19 quarters since. The position peaked at $79K in Q3 2021. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Private Capital Group held 1 share of Zimmer Biomet worth $0 as of Q2 2022.
Private Capital Group sold 539 Zimmer Biomet shares in Q2 2022, an estimated $63.9K.
Zimmer Biomet made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #2150 holding.
Private Capital Group first reported a position in Zimmer Biomet in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Zimmer Biomet position peaked at $79K in Q3 2021.
957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.